Rayner appoints esteemed ophthalmic leaders as strategic advisors and is awarded IDE for trifocal IOLs
-
Rayner Unveils Exciting Enhancements to Digital Platforms at ESCRS 2023, Booth B303
Read More -
Rayner Achieves Milestone Implantations in Landmark Clinical Trials in China and the USA
Read More -
Rayner Achieves Major Milestone With Implantation of 4 Millionth RayOne IOL
Read More -
Rayner Appoints Geoff Allan as Chief Financial Officer
Read More -
Evertreen Partnership
Read More -
Rayner launches ‘Peer2Peer: The Podcast’ for clinical education on the move
Read More